Acute myocardial infarction (AMI) is considered to be one of the predominant causes of human death; therefore, a rapid and accurate diagnostic method of AMI is urgently required. In this work, a highly sensitive lateral flow immunoassay (LFIA) platform was designed and fabricated for the quantitative determination of cardiac troponin I (cTnI) using a scanner, a smartphone and a colloidal gold immunoassay analyzer. To overcome the limitation of low sensitivity of traditional colloidal gold-based LFIA, the three-dimensionally assembled gold nanoparticles (AuNPs) within dendritic mesoporous silica nanoparticles (DMSNs) scaffold were fabricated as signal labels. The assembly structure greatly enhanced the light extinction ability of a single label for signal amplification. The DMSN@Au-based LFIA strips exhibited excellent detection performance including a high sensitivity (LOD=70 pg mL-1) and wide linear range (0.5–40 ng mL-1) and precision with good specificity. The successfully determination of cTnI by the test strips provides the ability to diagnose AMI at an early stage and expands the diagnostic window of AMI, while also having the advantages such as low cost and user-friendliness. Therefore, we believe that the test strips fabricated in this work have great potential to be applied for the practical clinical applications for the early and accurate diagnosis of AMI.

You have access to this article

Please wait while we load your content... Something went wrong. Try again?